(Q50519357)

English

Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report.

scientific article published on 22 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

author name string

Tadashi Inuzuka

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Hiroki Nishikawa

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Akira Sekikawa

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Haruhiko Takeda

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Shinichiro Henmi

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Azusa Sakamoto

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Sumio Saito

7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Ryuichi Kita

8

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Toru Kimura

9

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Yukio Osaki

10

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

publication date

22 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

81 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

152-157

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Systemic therapy for advanced hepatocellular carcinoma: a review.

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: a case report

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Complete response for advanced liver cancer during sorafenib therapy: case report

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report.

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection.

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000333279

21 January 2018

Identifiers

10.1159/000333279

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22212950

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50519357&oldid=1501830122"